Barbara Sarholz

Suggest Changes
Learn More
The First-Line Erbitux in Lung Cancer (FLEX) trial showed that the addition of cetuximab to chemotherapy followed by weekly cetuximab maintenance significantly improved survival in the first-line(More)
  • 1